FWIA
JAZZ icon

Fort Washington Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fort Washington Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$204K – 430
2025
Q4 		$204K Buy
+1,200
New +$184K ﹤0.01% 412
2023
Q2 		– Sell
-1,571
Closed -$230K – 389
2023
Q1 		$230K Buy
+1,571
New +$232K ﹤0.01% 368
2022
Q3 		– Sell
-1,790
Closed -$279K – 411
2022
Q2 		$279K Sell
1,790
-42
-2% -$6.47K ﹤0.01% 377
2022
Q1 		$285K Buy
+1,832
New +$266K ﹤0.01% 464
2021
Q3 		– Sell
-1,212
Closed -$215K – 513
2021
Q2 		$215K Buy
+1,212
New +$210K ﹤0.01% 495
2021
Q1 		– Sell
-1,232
Closed -$203K – 504
2020
Q4 		$203K Buy
+1,232
New +$183K ﹤0.01% 485
2017
Q3 		– Sell
-2,316
Closed -$360K – 515
2017
Q2 		$360K Sell
2,316
-2,659
-53% -$407K 0.01% 418
2017
Q1 		$722K Buy
+4,975
New +$648K 0.01% 357

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fort Washington Investment Advisors's JAZZ Position: Q1 2026 in Review

Fort Washington Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 1,200 shares — an estimated $204K sold.

Fort Washington Investment Advisors first reported a position in JAZZ in Q1 2017 and held it in 8 quarters. The position peaked at $722K in Q1 2017. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fort Washington Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 1,200 Jazz Pharmaceuticals shares in Q1 2026, an estimated $204K.
  • Fort Washington Investment Advisors first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Fort Washington Investment Advisors's Jazz Pharmaceuticals position peaked at $722K in Q1 2017.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.